Rapt Therapeutics (RAPT)
(Real Time Quote from BATS)
$4.39 USD
+0.06 (1.39%)
Updated May 13, 2024 01:44 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.79 |
EPS Last Quarter | -0.79 |
Last EPS Surprise | -1.28% |
ABR | 1.83 |
Earnings ESP
|
16.72% |
---|---|
Current Year | -3.16 |
Next Year | -2.15 |
EPS (TTM) | -3.07 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.53M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.79 | -0.71 | -3.16 | -2.15 |
# of Estimates | 4 | 4 | 6 | 3 |
Most Recent Consensus | -0.83 | -0.84 | -3.26 | -2.53 |
High Estimate | -0.66 | -0.51 | -2.54 | -1.57 |
Low Estimate | -0.88 | -0.93 | -4.12 | -2.53 |
Year ago EPS | -0.66 | -0.82 | -3.05 | -3.16 |
Year over Year Growth Est. | -19.70% | 13.41% | -3.61% | 31.91% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.79 | -0.71 | -3.16 | -2.15 |
7 Days Ago | -0.80 | -0.73 | -3.19 | -2.40 |
30 Days Ago | -0.80 | -0.73 | -3.19 | -2.40 |
60 Days Ago | -0.81 | -0.74 | -3.21 | -2.65 |
90 Days Ago | -0.85 | -0.81 | -3.48 | -3.99 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.66 | -0.57 | -2.61 | -2.35 |
Zacks Consensus Estimate | -0.79 | -0.71 | -3.16 | -2.15 |
Earnings ESP | 16.72% | 20.00% | 17.36% | -9.30% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.79 | -0.80 | -0.82 | -0.66 | NA |
Estimate | -0.78 | -0.85 | -0.75 | -0.80 | NA |
Difference | -0.01 | 0.05 | -0.07 | 0.14 | 0.03 |
Surprise | -1.28% | 5.88% | -9.33% | 17.50% | 3.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more